Thank you very much for your testimony. I see you have with you the vice-president of the common drug review, Mike Tierney, and Braden Manns, chair of the Canadian Expert Drug Advisory Committee, is with you as well.
Now we'll go to our final presenter from British Columbia, Robert Nakagawa.